HIV and Cognitive Impairment: Understanding HAND

HIV does not directly destroy neurons. Instead, it infects and activates glial cells (microglia, astrocytes) in the central nervous system, triggering chronic neuroinflammation and releasing neurotoxic viral proteins (gp120, Tat) and inflammatory cytokines. This indirect injury underlies HIV-Associated Neurocognitive Disorders (HAND).

HAND Spectrum

  • Asymptomatic Neurocognitive Impairment (ANI): Test abnormalities only; no functional decline.
  • Mild Neurocognitive Disorder (MND): Mild functional interference.
  • HIV-Associated Dementia (HAD): Severe cognitive, motor, and behavioral impairment (now rare with ART).

Common Symptoms

  • Memory loss, slowed processing, difficulty concentrating.
  • Executive dysfunction (planning, decision-making).
  • Mood changes, apathy, psychosis (less common).
  • Motor slowing, gait instability, tremor.

Management

  • Effective ART: Suppresses viral replication in CNS; cornerstone of prevention and treatment.
  • Neuropsychological testing for baseline and monitoring.
  • Manage cardiovascular risk factors (diabetes, hypertension) that exacerbate cognitive decline.
  • Symptomatic treatment for depression, sleep disorders, neuropathic pain.

With modern ART, severe HAND is uncommon, but milder forms persist in 30–50% of people with HIV. Regular cognitive screening is recommended.

HIV & AIDS - Related Articles